SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹-2,731 Cr | ₹-1,998 Cr | ₹-1,316 Cr | ₹-1,515 Cr | ₹246 Cr |
What is the latest Total Non-Current Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹-2,731 Cr |
Mar2023 | ₹-1,998 Cr |
Mar2022 | ₹-1,316 Cr |
Mar2021 | ₹-1,515 Cr |
Mar2020 | ₹246 Cr |
How is Total Non-Current Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-2,731 Cr | Negative | |
Mar2023 | ₹-1,998 Cr | Negative | |
Mar2022 | ₹-1,316 Cr | Negative | |
Mar2021 | ₹-1,515 Cr | Negative | |
Mar2020 | ₹246 Cr | - |
Compare Total Non-Current Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹395,248.7 Cr | -2.5% | -4.9% | 8.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹172,374.0 Cr | -2.7% | -0.9% | 42.5% | Stock Analytics | |
CIPLA | ₹119,795.0 Cr | -1.5% | 0.1% | -4.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,698.0 Cr | -2.6% | 8.3% | 7.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,218.0 Cr | -2.6% | -3.7% | 11.9% | Stock Analytics | |
MANKIND PHARMA | ₹95,866.6 Cr | -2.5% | -8.3% | 5.2% | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | -2.5% |
-4.9% |
8.7% |
SENSEX | -0.4% |
0.2% |
5.9% |
You may also like the below Video Courses